These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Ammonia and GABA-ergic neurotransmission in pathogenesis of hepatic encephalopathy]. Helewski K, Kowalczyk-Ziomek G, Konecki J. Wiad Lek; 2003 Jul; 56(11-12):560-3. PubMed ID: 15058165 [Abstract] [Full Text] [Related]
7. Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands. Gammal SH, Basile AS, Geller D, Skolnick P, Jones EA. Hepatology; 1990 Mar; 11(3):371-8. PubMed ID: 2155865 [Abstract] [Full Text] [Related]
8. Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathy. Basile AS, Harrison PM, Hughes RD, Gu ZQ, Pannell L, McKinney A, Jones EA, Williams R. Hepatology; 1994 Jan; 19(1):112-21. PubMed ID: 8276347 [Abstract] [Full Text] [Related]
10. [GABA-benzodiazepine receptor complex: therapeutic role of benzodiazepine antagonists]. Andresen M, Arrese M, Dougnac A, Godoy J, Prat G, Chianale J. Rev Med Chil; 1989 Aug; 117(8):944-6. PubMed ID: 2562414 [No Abstract] [Full Text] [Related]